LUTERION's scientific strategy is based on the biological connection between mitochondrial dysfunction, maladaptive immune signaling, and impaired recovery after cellular or tissue injury.
Lu120819 is being developed for diseases where mitochondrial dysfunction contributes to pathological stress responses and impaired cellular recovery.
LUTERION's host-directed strategy focuses on immune-metabolic biology rather than direct pathogen- or symptom-only intervention.
The platform is being explored in disease areas involving tissue injury, remodeling, and insufficient recovery from cellular stress.